Pfizer’s Recent Study Shows Skin Disease Drug Way Effective than Regeneron Rival
Pfizer Inc.’s experimental drug for patients with moderate-to-severe atopic dermatitis met the main goals of improving symptoms in adult patients
Read morePfizer Inc.’s experimental drug for patients with moderate-to-severe atopic dermatitis met the main goals of improving symptoms in adult patients
Read morePfizer CEO, a US pharmacy corporation, has aims to make the coronavirus vaccine available in the US by the end
Read more